Lei Guo
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- MicroRNA in disease regulation 9
- Oncology 22
- Bone health and treatments 8
- Co-authors
- Qing‐Hai Ye (18 shared papers)Jubo Zhang (9 shared papers)Lianfu Deng (15 shared papers)Ping Huang (16 shared papers)Xiaoqiang Li (7 shared papers)Qi Jin (11 shared papers)Shuang Liu (4 shared papers)Yufei Yan (10 shared papers)
- Journals
- Journal of Medicinal Chemistry (4 papers)Journal of Cellular Physiology (3 papers)Cell Death and Disease (3 papers)Scientific Reports (3 papers)BioMed Research International (2 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Lei Guo
107 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 147
- Cancer Research 667
- Hepatology 308
- Rehabilitation 151
- Biochemistry 164
- Oncology 528
Countries citing papers authored by Lei Guo
This map shows the geographic impact of Lei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Guo more than expected).
Fields of papers citing papers by Lei Guo
This network shows the impact of papers produced by Lei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Guo. The network helps show where Lei Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Lei Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 187 | |
| 2 | 2017 | 165 | |
| 3 | 2016 | 131 | |
| 4 | 2013 | 120 | |
| 5 | 2016 | 115 | |
| 6 | 2022 | 112 | |
| 7 | 2010 | 97 | |
| 8 | 2013 | 87 | |
| 9 | 2022 | 85 | |
| 10 | 2019 | 81 | |
| 11 | 2014 | 80 | |
| 12 | 2010 | 77 | |
| 13 | Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma. | 2019 | 71 |
| 14 | 2016 | 69 | |
| 15 | 2016 | 68 | |
| 16 | 2023 | 65 | |
| 17 | 2016 | 64 | |
| 18 | 2020 | 55 | |
| 19 | 2018 | 53 | |
| 20 | 2012 | 51 |
About Lei Guo
Lei Guo is a scholar working on Cancer Research, Oncology, Molecular Biology, Hepatology and Pathology and Forensic Medicine, having authored 109 papers that have together received 3.6k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (14 papers), MicroRNA in disease regulation (9 papers), Bone health and treatments (8 papers), Sulfur Compounds in Biology (8 papers), Circular RNAs in diseases (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Glaucoma and retinal disorders (5 papers) and Spine and Intervertebral Disc Pathology (5 papers). The work is most often cited by research in Cancer Research (667 citations), Hepatology (308 citations), Rehabilitation (151 citations), Biochemistry (164 citations) and Oncology (528 citations). Lei Guo has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Qing‐Hai Ye, Jubo Zhang, Lianfu Deng, Ping Huang, Xiaoqiang Li, Qi Jin, Shuang Liu, Yufei Yan, Changwei Li and Hao Chen. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Cellular Physiology, Cell Death and Disease, Scientific Reports and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.